lapatinib 250 mg Lapatem Tablet

Trade Name: Lapatem

Manufacturer: Emcure

Presentation: Tablet

Strength: 250mg

 

What is the function of Lapatinib 250 mg?

Lapatinib 250 mg is a drug that is used with capecitabine (Xeloda) to treat a specific form of advanced breast cancer in people who have already received other types of chemotherapy.

Is Lapatinib 250 mg an anti-cancer drug?

Chemotherapy Drugs – Chemocare – Lapatinib

What is the mechanism of action of lapatinib in breast cancer?

Tykerb (lapatinib) is a HER2 inhibitor that is used to treat the infection. Tykerb inhibits specific proteins that can induce uncontrolled cell proliferation in HER2-positive breast tumors.

Is lapatinib approved by the FDA?

The US Food and Drug Administration (FDA) has endorsed lapatinib (Tykerb) in blend with capecitabine (Xeloda) for the therapy of patients with cutting edge or metastatic bosom malignant growth whose cancers overexpress HER2 and who have previously undergone anthracycline, taxane, or trastuzumab (Herceptin).

Who is the manufacturer of lapatinib?

The medicine is marketed by GlaxoSmithKline (GSK) under the brand names Tykerb (primarily in the United States) and Tyverb (mainly in Europe) (mostly in Europe and Russia).

Is it true that lapatinib causes weight gain?

  • Shortness of breath or other breathing difficulties, cough, or fever is all signs of lung or breathing disorders. Shortness of breath, significant weight gain, or swelling in the arms or legs are all signs that something is wrong.
  • Dizziness. Severe diarrhea or diarrhea accompanied by stomach cramps, nausea, vomiting, fever, or fluid loss.

Read more

Is lapatinib able to pass across the blood-brain barrier?

Because of its tiny molecular form, lapatinib is able to pass the blood-brain barrier. When used alone or in combination with other drugs, lapatinib has been found to inhibit the development of brain metastases in breast cancer patients.

Is it true that lapatinib causes hair loss?

Oral breast cancer medications such as capecitabine (Xeloda) and lapatinib (Tykerb) can cause hair thinning rather than the severe alopecia that some intravenous chemotherapy treatments can produce.

We are a global wholesaler and exporter based in India, with operations in more than five countries including the United Arab Emirates, Saudi Arabia, Oman, Qatar, and Myanmar. enduring you are looking for another product or brand click here.